Work

figure S6 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity

Year: 2023

Type: other

Abstract: Suppl fig 6: Immunocompetent non-tumor bearing mice injected IP daily with increasing concentrations of drug 3g for 21 days followed by harvest of serum for assays of alkaline phosphatase, ALT, AST, bilirubin and BUN. Chemistry values of control mice injected daily with DMSO (3g dose=0) were arbitrarily made '1'. Data are means+/-SD, N=4 mice/group.

DOI: 10.1158/1535-7163.22504392.v1

Authors: Mario I. Vega, Yijiang Shi, Patrick Frost, Sara Huerta-Yepez, Gabriela Antonio-Andres, Rogelio Hernandez-Pando, Jihye Lee, Michael E. Jung, Joseph F. Gera, Alan Lichtenstein

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362494835

Cites:

Cited by:

Related to: 10